The funding came from investors within the spine industry and the Genesis Innovation Group, according to a Nov. 8 news release. Happe Spine plans to use the money to launch an implant for spinal fusions.
Happe Spine has a proprietary material platform, HydroxyApatite Porous Peek, for implants. The material’s allograft-like qualities are designed to help improve clinical outcomes in interbody spinal fusions.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
